Demant A/S (OTCMKTS:WILYY) Given Average Rating of “Hold” by Brokerages

Shares of Demant A/S (OTCMKTS:WILYYGet Rating) have earned a consensus recommendation of “Hold” from the eight ratings firms that are covering the company, MarketBeat reports. Three analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $192.67.

A number of research firms have recently issued reports on WILYY. Jefferies Financial Group lowered Demant A/S from a “buy” rating to a “hold” rating in a research report on Wednesday, January 25th. BNP Paribas downgraded Demant A/S from an “outperform” rating to a “neutral” rating in a research note on Wednesday, January 25th. Barclays boosted their price target on shares of Demant A/S from 170.00 to 180.00 in a research report on Tuesday, November 22nd. Handelsbanken upgraded shares of Demant A/S from a “market perform” rating to an “outperform” rating in a research report on Monday, January 30th. Finally, Danske upgraded shares of Demant A/S from a “hold” rating to a “buy” rating in a report on Wednesday, February 8th.

Demant A/S Stock Performance

Shares of OTCMKTS WILYY opened at $15.58 on Friday. The company has a quick ratio of 0.59, a current ratio of 0.78 and a debt-to-equity ratio of 0.39. Demant A/S has a 12-month low of $11.19 and a 12-month high of $23.06. The company has a 50-day moving average of $14.97 and a 200 day moving average of $14.08.

About Demant A/S

(Get Rating)

Demant A/S engages in the development, manufacture, and sale of products and equipment designed to aid the hearing and communication of individuals. It operates through the Hearing Healthcare and Communications segments. The Hearing Healthcare segment focuses on the following business areas: Hearing Aids, Hearing Care, and Diagnostics, which provide hearing Healthcare solutions involving manufacturing, servicing, and sale of hearing aids, diagnostics products, and services.

Read More

Analyst Recommendations for Demant A/S (OTCMKTS:WILYY)

Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with's FREE daily email newsletter.